European equities traded in the US as American depositary receipts were lower on Friday morning, down 0.3% to 1,457.10 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company Evaxion (EVAX) and pharmaceutical company Grifols (GRFS), which rose 5.5% and 1.6% respectively.
They were followed by energy company Eni (E), which was adding 1%.
The decliners from continental Europe were led by pharmaceutical research company Galapagos (GLPG) and biopharmaceutical firm DBV Technologies (DBVT), which fell 3.4% and 2.9% respectively.
They were followed by semiconductor company ASML (ASML), which was down 2.4%.
From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and telecom provider Vodafone (VOD), which rose 2% and 1.5% respectively.
The decliners from the UK and Ireland were led by pharmaceutical companies Compass Pathways (CMPS) and Centessa Pharmaceuticals (CNTA), which declined 5.8% and 2.8% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。